van Spronsen FJ, van Wegberg AM, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743–56.
Article
PubMed
Google Scholar
van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.
Article
PubMed
PubMed Central
Google Scholar
Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188–200.
Article
CAS
PubMed
Google Scholar
Blau N. Genetics of phenylketonuria: then and now. Hum Mutat. 2016;37(6):508–15.
Article
CAS
PubMed
Google Scholar
PAHvdb: Phenylalanine Hydroxylase Gene Locus-Specific Database. 2020. http://www.biopku.org/home/pah.asp. Accessed 4 Sept 2020.
Opladen T, López-Laso E, Cortès-Saladelafont E, Pearson TS, Sivri HS, Yildiz Y, et al. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH(4)) deficiencies. Orphanet J Rare Dis. 2020;15(1):126.
Article
PubMed
PubMed Central
Google Scholar
Williams RA, Mamotte CD, Burnett JR. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev. 2008;29(1):31–41.
PubMed
PubMed Central
Google Scholar
Anikster Y, Haack TB, Vilboux T, Pode-Shakked B, Thony B, Shen N, et al. Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet. 2017;100(2):257–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
MacDonald A, van Wegberg AMJ, Ahring K, Beblo S, Bélanger-Quintana A, Burlina A, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):171.
Article
CAS
PubMed
PubMed Central
Google Scholar
MacDonald A, van Wegberg AMJ, Ahring K, Beblo S, Bélanger-Quintana A, Burlina A, et al. Correction to: PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):230.
Article
CAS
PubMed
PubMed Central
Google Scholar
European Medicines Agency. Palynziq—Summary of product characteristics. 2019. https://www.ema.europa.eu/en/documents/product-information/palynziq-epar-product-information_en.pdf. Accessed 4 Sept 2020.
FDA. Palynziq—US package insert. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf.
European Medicines Agency. Kuvan—Summary of product characteristics. 2020. https://www.ema.europa.eu/en/documents/product-information/kuvan-epar-product-information_en.pdf. Accessed 4 Sept 2020.
FDA. Kuvan - US package insert. 2007. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022181lbl.pdf. Accessed 4 Sep 2020.
Therrell BL, Padilla CD, Loeber JG, Kneisser I, Saadallah A, Borrajo GJ, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39(3):171–87.
Article
PubMed
Google Scholar
Zerjav Tansek M, Groselj U, Angelkova N, Anton D, Baric I, Djordjevic M, et al. Phenylketonuria screening and management in southeastern Europe—survey results from 11 countries. Orphanet J Rare Dis. 2015;30(10):68.
Article
Google Scholar
Borrajo GJC. Newborn screening for phenylketonuria: Latin American consensus guidelines. J Inborn Errors Metab Screen. 2016 2016/01/01;4:2326409816682764.
Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–43.
CAS
PubMed
Google Scholar
Chace DH, Hannon WH. Technological journey from colorimetric to tandem mass spectrometric measurements in the diagnostic investigation for phenylketonuria. J Inborn Errors Metab Screen. 2016 2016/01/01;4:2326409816671733.
Blumenfeld CM, Wallace MJ, Anderson R. Phenylketonuria-the guthrie screening test-a method of quantitation, observations on reliability and suggestions for improvement. Calif Med. 1966;105(6):429–34.
CAS
PubMed
PubMed Central
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;21(339):b2535.
Article
Google Scholar
Silva LC, Ordunez P, Paz Rodriguez M, Robles S. A tool for assessing the usefulness of prevalence studies done for surveillance purposes: the example of hypertension. Rev Panam Salud Publica. 2001;10(3):152–60.
Article
CAS
PubMed
Google Scholar
Al-Jader LN, Newcombe RG, Hayes S, Murray A, Layzell J, Harper PS. Developing a quality scoring system for epidemiological surveys of genetic disorders. Clin Genet. 2002;62(3):230–4.
Article
CAS
PubMed
Google Scholar
United Nations. World population prospects 2019. File POP/1–1: total population (both sexes combined) by region, subregion and country, annually for 1950–2100 (thousands). 2019. https://population.un.org/wpp/. Accessed 28 May 28 2020.
Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Commun Health. 2013;67(11):974–8.
Article
Google Scholar
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M. Cochrane handbook for systematic reviews of interventions, version 6.0. 2019. https://training.cochrane.org/handbook. Accessed 5 March 2020.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Article
PubMed
PubMed Central
Google Scholar
Maccready RA, Hussey MG. Newborn phenylketonuria detection program in Massachusetts. Am J Public Health Nations Health. 1964;54:2075–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin Y, Zheng Q, Zheng T, Zheng Z, Lin W, Fu Q. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population. Clin Chim Acta. 2019;494:106–11.
Article
CAS
PubMed
Google Scholar
Carson NA, Carre IJ, Neill DW. Results of routine screening for phenylketonuria in early infancy, Northern Ireland (1960–1967). Arch Dis Child. 1968;43(228):145–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arnopp JJ, Lorey FW, Currier RJ, Eastman JW, Velazquez KB, Morales DR, et al. Results of screening for phenylketonuria using a lower cutoff value in early collected specimens. Screening. 1995;3(4):193–9.
Article
CAS
Google Scholar
Martin PH. Six years of newborn PKU screening. J Indiana State Med Assoc. 1968;61(8):1107–8.
CAS
PubMed
Google Scholar
Yang LL, Mao HQ, Zhang WF, Zhao ZY, Yang RL, Zhou XL, et al. Pitfalls in the management of phenylketonuria in China. Hong Kong J Paediatr. 2012;17(3):143–7.
Google Scholar
Boneh A, Francis DE, Humphrey M, Upton HJ, Peters HL. Three-year audit of the hyperphenylalaninaemia/phenylketonuria spectrum in Victoria. J Paediatr Child Health. 2006;42(9):496–8.
Article
PubMed
Google Scholar
Read KS, Allen RJ, Haddy TB. Phenylketonuria in newborns. Mich Med. 1969;68(13):691–7.
CAS
PubMed
Google Scholar
Ervin EN. Hyperphenylalanemia. Incidence in Maine since 1964. J Maine Med Assoc. 1970;61(2):30–2.
CAS
PubMed
Google Scholar
Somers DG, Favreau L. Newborn screening for phenylketonuria: incidence and screening procedures in North America. Can J Public Health. 1982;73(3):206–7.
CAS
PubMed
Google Scholar
Ounap K, Lilleväli H, Metspalu A, Lipping-Sitska M. Development of the phenylketonuria screening programme in Estonia. J Med Screen. 1998;5(1):22–3.
Article
CAS
PubMed
Google Scholar
Visakorpi JK, Palo J, Renkonen OV. The incidence of PKU in Finland. Acta Paediatr Scand. 1971;60(6):666–8.
Article
CAS
PubMed
Google Scholar
Ratrisawadi V, Horpaopan S, Chotigeat U, Sangtawesin V, Kanjanapattanakul W, Ningsanond V, et al. Neonatal screening program in Rajavithi Hospital, Thailand. Southeast Asian J Trop Med Public Health. 1999;30(Suppl 2):28–32.
PubMed
Google Scholar
Kocova M, Anastasovska V. Phenylketonuria screening in the Republic of Macedonia. Orphanet J Rare Dis. 2016;11(1):112.
Article
PubMed
PubMed Central
Google Scholar
Frazier DM, Millington DS, McCandless SE, Koeberl DD, Weavil SD, Chaing SH, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005. J Inherit Metab Dis. 2006;29(1):76–85.
Article
CAS
PubMed
Google Scholar
Wainer SC, Sideman L. Nine years of PKU screening in Pennsylvania. Health Lab Sci. 1974;11(4):306–11.
CAS
PubMed
Google Scholar
Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH. Incidence of phenylketonuria in Southern Iran. Iran J Med Sci. 2010;35(2):137–9.
Google Scholar
Hamamy H, Antonarakis SE, Cavalli-Sforza LL, Temtamy S, Romeo G, Kate LP, et al. Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report. Genet Med. 2011;13(9):841–7.
Article
PubMed
Google Scholar
Hillert A, Anikster Y, Belanger-Quintana A, Burlina A, Burton BK, Carducci C, et al. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shoraka HR, Haghdoost AA, Baneshi MR, Bagherinezhad Z, Zolala F. Global prevalence of classic phenylketonuria based on Neonatal Screening Program data: systematic review and meta-analysis. Clin Exp Pediatr. 2020;63(2):34–43.
Article
PubMed
PubMed Central
Google Scholar
Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934–9.
Article
PubMed
Google Scholar
Thalhammer O. Distribution and frequency of PKU and hyperphenylalaninemia in eastern and western Austria. Ir Med J. 1976;69(15):396–7.
CAS
PubMed
Google Scholar
Lindner M, Gramer G, Haege G, Fang-Hoffmann J, Schwab KO, Tacke U, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases–report of 10 years from South-West Germany. Orphanet J Rare Dis. 2011;6:44.
Article
PubMed
PubMed Central
Google Scholar
Mathias D, Bickel H. Follow-up study of 16 years neonatal screening for inborn errors of metabolism in West Germany. Eur J Pediatr. 1986;145(4):310–2.
Article
CAS
PubMed
Google Scholar
Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics. 2003;111(6 Pt 1):1399–406.
Article
PubMed
Google Scholar
Loukas YL, Soumelas GS, Dotsikas Y, Georgiou V, Molou E, Thodi G, et al. Expanded newborn screening in Greece: 30 months of experience. J Inherit Metab Dis. 2010;33(Suppl 3):S341–8.
Article
PubMed
Google Scholar
Missiou-Tsagaraki S, Soulpi K, Loumakou M. Phenylketonuria in Greece: 12 years’ experience. J Ment Defic Res. 1988;32(Pt 4):271–87.
PubMed
Google Scholar
Mehes K, Juhasz E, Ruszinko V. Chromatographic screening of 70,328 neonates for inborn errors of amino acid metabolism. Acta Paediatr Hung. 1985;26(2):147–9.
CAS
PubMed
Google Scholar
Antonozzi I, Dominici R, Andreoli M, Monaco F. Neonatal screening in Italy for congenital hypothyroidism and metabolic disorders: hyperphenylalaninemia, maple syrup urine disease and homocystinuria. J Endocrinol Invest. 1980;3(4):357–63.
Article
CAS
PubMed
Google Scholar
Zaffanello M, Zamboni G, Tatò L. Neonatal screening program for inborn errors of metabolism: a retrospective study from 1978 to 1997 in Northeastern Italy. Ital J Pediatr. 2002;28:479–83.
Google Scholar
Cabalska B, Nowaczewska I, Duczynska N, Laskowska-Klita T. Twenty-five years experience with newborn screening for phenylketonuria (PKU) in Poland. Screening. 1993;2(1):29–32.
Article
Google Scholar
Vilarinho L, Rocha H, Sousa C, Marcao A, Fonseca H, Bogas M, et al. Four years of expanded newborn screening in Portugal with tandem mass spectrometry. J Inherit Metab Dis. 2010;33(Suppl 3):S133–8.
Article
PubMed
Google Scholar
Dluholucký S, Knapková M. Newborn screening in Slovakia—from 1985 till today/Novorodencký skríning na Slovensku—od roku 1985 doposiaľ. Acta Facul Pharm Univ Comen. 2013;60(Suppl VIII):32–6.
Smon A, Groselj U, Zerjav Tansek M, Bicek A, Oblak A, Zupancic M, et al. Newborn screening in Slovenia. Zdr Varst. 2015;54(2):86–90.
PubMed
PubMed Central
Google Scholar
Fernández-Iglesias C, Flórez IG, Rodríguez-González MC, Gascón S. Neonatal screening for phenylketonuria and congenital hypothyroidism in Principado de Asturias (Spain) using two types of blood samples. Screening. 1995;4(3):131–8.
Article
Google Scholar
Gerasimova NS, Samutin AA, Steklova IV, Tuuminen T. Phenylketonuria screening in Moscow using a microplate fluorometric method. Screening. 1992;1(1):27–35.
Article
CAS
Google Scholar
Walker V, Clayton BE, Ersser RS, Francis DE, Lilly P, Seakins JW, et al. Hyperphenylalaninaemia of various types among three-quarters of a million neonates tested in a screening programme. Arch Dis Child. 1981;56(10):759–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mardesic D, Gjuric G, Jancikovic J. Screening for phenylketonuria in Yugoslavia (SR Crotia) 1979–1984. J Inherit Metab Dis. 1986;9(Suppl 2):234–6.
Article
Google Scholar
Botler J, Camacho LA, Cruz MM. Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program. Cad Saude Publica. 2012;28(9):1623–31.
Article
PubMed
Google Scholar
Ramalho AR, Ramalho RJ, Oliveira CR, Magalhaes MM, Santos EG, Sarmento PM, et al. Evaluation of effectiveness and outcome of PKU screening and management in the state of Sergipe. Brazil Arq Bras Endocrinol Metabol. 2014;58(1):62–7.
Article
PubMed
Google Scholar
Cornejo V, Raimann E, Cabello JF, Valiente A, Becerra C, Opazo M, et al. Past, present and future of newborn screening in Chile. J Inherit Metab Dis. 2010;33(Suppl 3):S301–6.
Article
PubMed
Google Scholar
Abbaskhanian A, Zamanfar D, Afshar P, Asadpoor E, Rouhanizadeh H, Jafarnia A, et al. Incidence of neonatal hyperphenylalaninemia based on high-performance liquid chromatography confirmatory technique in Mazandaran province, northern Iran (2007–2015). Int J Prev Med. 2017;8:93.
PubMed
PubMed Central
Google Scholar
Karamifar H, Ordoei M, Karamizadeh Z, Amirhakimi G. Incidence of neonatal hyperphenylalaninemia in Fars province, south Iran. Iran J Pediatr. 2010;20(2):216–20.
PubMed
PubMed Central
Google Scholar
Motamedi N, Godarzi E, Pordanjani SR, Valizadeh R, Moradi Y, Sohrabivafa M, et al. Incidence of phenylketonuria in Lorestan province, west of Iran (2006–2016). Int J Pediatr. 2017;5(4):4713–21.
Google Scholar
Alfadhel M, Al Othaim A, Al Saif S, Al Mutairi F, Alsayed M, Rahbeeni Z, et al. Expanded newborn screening program in Saudi Arabia: incidence of screened disorders. J Paediatr Child Health. 2017;53(6):585–91.
Article
PubMed
Google Scholar
Ozalp I, Coskun T, Tokatli A, Kalkanoglu HS, Dursun A, Tokol S, et al. Newborn PKU screening in Turkey: at present and organization for future. Turk J Pediatr. 2001;43(2):97–101.
CAS
PubMed
Google Scholar
Al Hosani H, Salah M, Osman HM, Farag HM, El-Assiouty L, Saade D, et al. Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011. East Mediterr Health J. 2014;20(1):17–23.
Article
CAS
PubMed
Google Scholar
Hansen H, Shahidi A, Stein ZA. Screening for phenylketonuria in New York City Threshold values reconsidered. Public Health Rep. 1978;93(3):246–51.
CAS
PubMed
PubMed Central
Google Scholar
Kelly S, Palombi J. Phenylketonuria in New York State. Public Health Rep. 1967;82(10):921–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem. 2001;47(11):1945–55.
Article
CAS
PubMed
Google Scholar
Charoensiriwatana W, Janejai N, Boonwanich W, Krasao P, Chaisomchit S, Waiyasilp S. Neonatal screening program in Thailand. Southeast Asian J Trop Med Public Health. 2003;34(Suppl 3):94–100.
PubMed
Google Scholar
Pangkanon S, Ratrisawadi V, Charoensiriwatana W, Techasena W, Boonpuan K, Srisomsap C, et al. Phenylketonuria detected by the neonatal screening program in Thailand. Southeast Asian J Trop Med Public Health. 2003;34(Suppl 3):179–81.
PubMed
Google Scholar
Pangkanon S, Charoensiriwatana W, Janejai N, Boonwanich W, Chaisomchit S. Detection of phenylketonuria by the newborn screening program in Thailand. Southeast Asian J Trop Med Public Health. 2009;40(3):525–9.
CAS
PubMed
Google Scholar
Sutivijit Y, Banpavichit A, Wiwanitkit V. Prevalence of neonatal hypothyroidism and phenylketonuria in Southern Thailand: a 10-year report. Indian J Endocrinol Metab. 2011;15(2):115–7.
Article
PubMed
PubMed Central
Google Scholar
Chen RG, Pan XS, Qian DL, Guo H. Twenty-one cases of phenylketonuria out of 358,767 newborns in Shanghai, China. J Inherit Metab Dis. 1989;12(4):485.
Article
CAS
PubMed
Google Scholar
Liu SR, Zuo QH. Newborn screening for phenylketonuria in eleven districts. Chin Med J (Engl). 1986;99(2):113–8.
CAS
Google Scholar
Maitusong R, Japaer R, Zhao ZY, Yang RL, Huang XL, Mao HQ. Newborn screening in Zhejiang. China Chin Med J (Engl). 2012;125(4):702–4.
Google Scholar
Shi XT, Cai J, Wang YY, Tu WJ, Wang WP, Gong LM, et al. Newborn screening for inborn errors of metabolism in mainland china: 30 years of experience. JIMD Rep. 2012;6:79–83.
Article
PubMed
PubMed Central
Google Scholar
Su Y, Wang H, Rejiafu N, Wu B, Jiang H, Chen H, et al. The molecular epidemiology of hyperphenylalaninemia in Uygur population: incidence from newborn screening and mutational spectra. Ann Transl Med. 2019;7(12):258.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tu WJ, Cai J, Shi XD. Newborn screening for inborn errors of metabolism in Beijing, China: 22 years of experience. J Med Screen. 2011;18(4):213–4.
Article
PubMed
Google Scholar
Wang X, He Y, Jiang Y, Feng X, Zhang G, Xia Z, et al. Screening and mutation analysis of hyperphenylalaninemia in newborns from Xiamen. China Clin Chim Acta. 2019;498:161–6.
Article
CAS
PubMed
Google Scholar
Zhan JY, Qin YF, Zhao ZY. Neonatal screening for congenital hypothyroidism and phenylketonuria in China. World J Pediatr. 2009;5(2):136–9.
Article
PubMed
Google Scholar
Yoon HR, Lee KR, Kang S, Lee DH, Yoo HW, Min WK, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta. 2005;354(1–2):167–80.
Article
CAS
PubMed
Google Scholar
Niu DM, Chien YH, Chiang CC, Ho HC, Hwu WL, Kao SM, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis. 2010;33(Suppl 2):S295-305.
Article
PubMed
Google Scholar